|
|
Volumn 36, Issue 3, 2000, Pages 298-301
|
|
Do we need better prognostic factors in nodal-negative breast cancer? Contra:
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
CATHEPSIN D;
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
METHOTREXATE;
ONCOPROTEIN;
TAMOXIFEN;
UROKINASE;
ADJUVANT THERAPY;
ARTICLE;
BONE MARROW CELL;
BREAST CANCER;
COMBINATION CHEMOTHERAPY;
DECISION MAKING;
DISEASE COURSE;
DRUG SENSITIVITY;
HUMAN;
LYMPH NODE METASTASIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENT DISEASE;
RISK FACTOR;
SURVIVAL RATE;
SURVIVAL TIME;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
HUMANS;
LYMPH NODES;
NEOPLASM STAGING;
PATIENT SELECTION;
PROGNOSIS;
TREATMENT OUTCOME;
|
|
EID: 0033998222
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(99)00302-0 Document Type: Article |
|
Times cited : (2)
|
|
References (25)
|
